Down 99%, this stock has been crushed by AI and is now a penny share!

Chegg has gone from being a fast-growth tech stock to a penny share trading for less than $1 in the space of four years. Ben McPoland explains why.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Frustrated young white male looking disconsolate while sat on his sofa holding a beer

Image source: Getty Images

The market has recently moved on from all things artificial intelligence (AI), focusing instead on global trade and tariffs. But in the background, the AI revolution continues apace and is disrupting some businesses. One is Chegg (NYSE: CHGG), which was trading for $113 in 2021 but is now priced as a penny share at $0.75.

That’s a shocking four-year decline of 99%!

An example of disruption

Chegg is an education technology company that offers services like textbook rentals, homework help, and study resources. Its customers are mainly college and high school students. 

However, as we know, generative AI bots like ChatGPT now — somewhat controversially — offer free help with homework and essays, undermining Chegg’s value proposition. Basically, students seem to be thinking: ‘why pay for Chegg when AI gives you free answers?’

In 2023, management said: “Since March we saw a significant spike in student interest in ChatGPT. We now believe it’s having an impact on our new customer growth rate.”

Chegg was right. In two years, its subscribers have gone from 5.1m to 3.2m, with revenue falling from $188m to $121m in that time. Worryingly, its cash position has fallen from $281m in Q1 2023 to just $44m at the end of March (and it’s now loss-making).

To try to improve things, the company is drastically cutting costs and exploring being acquired. Perhaps that can salvage some value (the market cap is now just $79m).

It’s also licensing its question-and-answer pairs to language model companies, though that appears to be a double-edged sword to me. Yes, it’s generating revenue by leveraging proprietary education data, but giving AI companies its content could cannibalise the core subscription business.

Today (12 May), Chegg’s management wrote: “We believe the trends impacting our business will worsen before they get better.”

Those “trends” are, of course, mainly declining subscribers due to competition from generative AI.

AI is not a single event

Many people have likened AI to the internet, but it does appear different to me.

While revolutionary, the internet was a one-time platform shift. But AI is not a single watershed moment. Rather, it’s a self-improving force, constantly learning and evolving, perhaps exponentially. 

Consequently, I expect a lot more disruption — and potential opportunities — in the years ahead.

This stock looks in no danger from AI

Of course, there will be some businesses that AI won’t hurt. It should even make them more efficient and profitable. Many of these can be found in the FTSE 100, including miners, global banks, and oil giants.

One UK stock that might be worth considering is AstraZeneca. It’s down 16% since March as investors worry about the Trump administration’s drive to lower drug prices in the US. This is a risk worth mentioning, as the US is AstraZeneca’s largest market.

However, in terms of AI, the technology could actually turbocharge the company’s drug discovery process. Not only that, but AstraZeneca has the wherewithal to really invest in its AI capabilities, unlike most smaller upstarts.

To me, the firm looks more likely to benefit from AI than be threatened by it. With the stock trading at a reasonable 15 times forward earnings, I think it’s worth a look.

Ben McPoland has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Black woman using smartphone at home, watching stock charts.
Investing Articles

Are investors running scared of Babcock and BAE Systems shares?

BAE Systems shares have had a brilliant run, and other UK defence stocks have been flying too. But Harvey Jones…

Read more »

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

As the FTSE 100 falls, savvy investors are looking for stocks to buy for the rebound

Many FTSE stocks have now fallen 10% or more from their 2026 highs. For long-term investors, exciting opportunities are emerging.

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

Should investors consider buying resilient Admiral Group and Tesco shares as markets wobble?

Harvey Jones is impressed by how Tesco shares have held up in the current market volatility, while Admiral has been…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Down 15% in a month and yielding 7.5%! Should I buy even more of my favourite dividend stock?

Harvey Jones says this brilliant FTSE 100 dividend stock is suddenly cheaper due to recent market volatility. And the yield…

Read more »

Abstract bull climbing indicators on stock chart
Growth Shares

3 growth shares for an ISA that have beaten the FTSE 100 for the past 5 years

Jon Smith points out several growth shares that have outperformed the broader market over a long period of time, with…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

Time’s running out for our 2025/26 Stocks and Shares ISA plans!

Never mind the stock market wobble, it's time to turn our attention to our Stocks and Shares ISA investments for…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

What might Warren Buffett think about today’s stock market?

Middle East conflict has given the UK stock market a bit of a hammering. But in the long-term scheme of…

Read more »

Man riding the bus alone
Dividend Shares

How big does my ISA need to be to make £2.5k in monthly passive income?

Jon Smith points out the key factors that go into building a dividend portfolio for passive income, and reviews one…

Read more »